Noda, Mitsuhiko http://orcid.org/0000-0003-0413-4631
Hayashino, Yasuaki
Yamazaki, Katsuya
Suzuki, Hikari
Goto, Atsushi
Kato, Masayuki
Izumi, Kazuo
Kobayashi, Masashi
Article History
Received: 13 June 2017
Accepted: 20 January 2020
First Online: 18 February 2020
Change Date: 19 October 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: The authors have read the journal’s policy and have the following conflicts: Dr. Noda serves as a chairperson of the evaluation committee of the Evidence-based Practice Guideline for the Treatment of Diabetes in Japan edited by Japan Diabetes Society. He also served as a member of the editorial committee of the Treatment Guide for Diabetes in Japan edited by Japan Diabetes Society and the Health Japan 21 (the second term) plan development committee. Dr. Noda received honoraria from Taisho Toyama Pharmaceutical Co. Ltd, MSD K.K., Novo Nordisk Pharma Ltd, outside of the submitted work. Other authors declare no competing financial or non-financial interest.